Alpha Cubed Investments, LLC Gilead Sciences, Inc. Transaction History

Alpha Cubed Investments, LLC

  • $2.24 Billion
  • Q3 2024

A detailed history of Alpha Cubed Investments, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alpha Cubed Investments, LLC holds 5,984 shares of GILD stock, worth $553,998. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,984
Previous 26,731 77.61%
Holding current value
$553,998
Previous $1.83 Million 72.68%
% of portfolio
0.02%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$66.59 - $83.99 $1.38 Million - $1.74 Million
-20,747 Reduced 77.61%
5,984 $501,000
Q2 2024

Jul 15, 2024
BUY
$63.15 - $72.88 $1.31 Million - $1.51 Million
20,784 Added 349.49%
26,731 $1.83 Million
Q1 2024

Apr 22, 2024
SELL
$71.58 - $87.29 $60,556 - $73,847
-846 Reduced 12.45%
5,947 $435,000
Q4 2023

Feb 05, 2024
SELL
$73.27 - $83.09 $79,204 - $89,820
-1,081 Reduced 13.73%
6,793 $550,000
Q3 2023

Oct 19, 2023
BUY
$73.94 - $80.67 $17,671 - $19,280
239 Added 3.13%
7,874 $590,000
Q2 2023

Jul 20, 2023
SELL
$76.01 - $86.7 $13,985 - $15,952
-184 Reduced 2.35%
7,635 $588,000
Q1 2023

Apr 26, 2023
SELL
$77.31 - $88.08 $1.74 Million - $1.99 Million
-22,546 Reduced 74.25%
7,819 $648,000
Q4 2022

Jan 25, 2023
BUY
$62.32 - $89.47 $35,771 - $51,355
574 Added 1.93%
30,365 $0
Q3 2022

Nov 03, 2022
BUY
$59.54 - $68.01 $69,721 - $79,639
1,171 Added 4.09%
29,791 $1.84 Million
Q1 2022

Apr 22, 2022
BUY
$57.92 - $72.58 $147,348 - $184,643
2,544 Added 9.76%
28,620 $1.7 Million
Q4 2021

Jan 19, 2022
BUY
$64.88 - $73.64 $8,369 - $9,499
129 Added 0.5%
26,076 $1.89 Million
Q3 2021

Oct 26, 2021
BUY
$67.69 - $73.03 $1,015 - $1,095
15 Added 0.06%
25,947 $1.81 Million
Q2 2021

Jul 20, 2021
SELL
$63.47 - $69.35 $17,898 - $19,556
-282 Reduced 1.08%
25,932 $1.79 Million
Q1 2021

Apr 23, 2021
BUY
$60.0 - $68.46 $3,660 - $4,176
61 Added 0.23%
26,214 $1.69 Million
Q4 2020

Jan 29, 2021
SELL
$56.65 - $64.55 $11,330 - $12,910
-200 Reduced 0.76%
26,153 $1.52 Million
Q3 2020

Oct 14, 2020
SELL
$62.1 - $78.08 $1.38 Million - $1.73 Million
-22,208 Reduced 45.73%
26,353 $1.67 Million
Q2 2020

Jul 13, 2020
SELL
$72.34 - $84.0 $7,306 - $8,484
-101 Reduced 0.21%
48,561 $3.74 Million
Q1 2020

Apr 10, 2020
BUY
$62.63 - $80.22 $1.34 Million - $1.72 Million
21,409 Added 78.56%
48,662 $3.64 Million
Q4 2019

Jan 17, 2020
SELL
$61.62 - $67.78 $99,886 - $109,871
-1,621 Reduced 5.61%
27,253 $1.77 Million
Q3 2019

Oct 18, 2019
BUY
$62.51 - $69.0 $205,157 - $226,458
3,282 Added 12.82%
28,874 $1.83 Million
Q2 2019

Jul 19, 2019
BUY
$61.87 - $69.38 $9,651 - $10,823
156 Added 0.61%
25,592 $1.73 Million
Q1 2019

Apr 26, 2019
SELL
$62.53 - $70.05 $104,174 - $116,703
-1,666 Reduced 6.15%
25,436 $1.65 Million
Q4 2018

Jan 29, 2019
SELL
$60.54 - $79.0 $174,597 - $227,836
-2,884 Reduced 9.62%
27,102 $1.7 Million
Q3 2018

Oct 25, 2018
BUY
$71.28 - $78.92 $206,498 - $228,631
2,897 Added 10.69%
29,986 $2.2 Million
Q2 2018

Jul 26, 2018
SELL
$64.88 - $75.68 $9,667 - $11,276
-149 Reduced 0.55%
27,089 $1.92 Million
Q1 2018

May 09, 2018
SELL
$72.84 - $88.8 $198,780 - $242,335
-2,729 Reduced 9.11%
27,238 $2.05 Million
Q4 2017

Feb 09, 2018
SELL
$71.15 - $83.52 $53,433 - $62,723
-751 Reduced 2.44%
29,967 $2.15 Million
Q3 2017

Oct 23, 2017
BUY
$72.11 - $85.47 $2.22 Million - $2.63 Million
30,718
30,718 $2.49 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Alpha Cubed Investments, LLC Portfolio

Follow Alpha Cubed Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Cubed Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email